Mortality from COVID-19
Keywords:
Covid-19 mortality, USA, ItalyAbstract
The differences of the epidemiology (incidence, case-to-death rate, mortality, etc) of COVID-19 between USA and Italy are analyzed taking into account the social, economic and sanitary characteristics of the two countries, both severely hit be the pandemic; and the causes of the so many different behaviors of the disease in each of them are discussed and explained.
References
1. Mahase E. Covid-19: Are cloth masks still effective? And other questions answered. BMJ 2021; 372: n432. doi: 10.1136/bmj.n432.
2. Chaudhry R, Dranitsaris G, Mubashir T, Bartoszko J, Riazi S. A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes. EClinicalMedicine 2020 Aug; 25: 100464. doi: 10.1016/j.eclinm.2020.100464. Epub 2020 Jul 21.
3. Woolf SH, Chapman DA, Lee JH. COVID-19 as the Leading Cause of Death in the United States. JAMA 2021; 325(2): 123-4. doi: 10.1001/jama.2020.24865.
4. Koh HK, Geller AC, VanderWeele TJ. Deaths From COVID-19. JAMA 2021; 325(2): 133-4. doi: 10.1001/ jama.2020.25381.
523
5. Johns Hopkins University. Coronavirus Resource Center. Mortality Analyses. Mortality in the most affected countries. Last update January 20 2021. Available at: https://coronavirus.jhu.edu/data/mortality [Last accessed: 2021 Mar 15].
6. Villani L, McKee M, Cascini F, Ricciardi W, Boccia S. Comparison of Deaths Rates for COVID-19 across Europe During the First Wave of the COVID-19 Pandemic. Front Public Health 2020; 8: 620416. doi:
10.3389/fpubh.2020.620416.
7. Bilinski A, Emanuel EJ. COVID-19 and Excess All-Cause Mortality in the US and 18 Comparison Countries. JAMA 2020; 324(20): 2100-2. doi: 10.1001/jama.2020.20717.
8. Signorelli C, Odone A, Gianfredi V, et al. COVID-19 mortality rate in nine high-income metropolitan regions. Acta Biomed 2020; 91(9-S): 7-18. doi: 10.23750/abm.v91i9-S.10134.
9. Signorelli C, Odone A, Gianfredi V, et al. F. The spread of COVID-19 in six western metropolitan regions:
a false myth on the excess of mortality in Lombardy and the defense of the city of Milan. Acta Biomed 2020; 91(2): 23-30. doi: 10.23750/abm.v91i2.9600.
10. ANSA. WHO pays tribute to Italy for COVID-19 response. Sept 25 2020. Available at: https://www.ansa.
it/english/news/general_news/2020/09/25/who-pays-tribute-to-italy-for-covid-19-response_2c44490e489b-4836-933a-d0fc79cbe753.html [Last accessed: 2021, Mar 15].
11. Hasell J, Mathieu, E, Beltekian D, et al. A cross-country database of COVID-19 testing. Sci Data 2020; 7(1): 345. doi: 10.1038/s41597-020-00688-8.
12. Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control 2020; 49(2): 238-46. doi: 10.1016/j. ajic.2020.06.213. Epub ahead of print.
13. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323(16): 1574-81. doi: 10.1001/jama.2020.5394.
14. Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line. N Engl J Med 2020; 382(20): 1873-5. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18.
15. Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med 2012; 38(10): 1647-53. doi: 10.1007/s00134-012-2627-8. Epub 2012 Jul 10.
16. Wallace DJ, Angus DC, Seymour CW, Barnato AE, Kahn JM. Critical care bed growth in the United States. A comparison of regional and national trends. Am J Respir Crit Care Med 2015; 191(4): 410-6. doi: 10.1164/rccm.201409-1746OC.
17. Joyner MJ, Bruno KA, Klassen SA, et al. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc 2020; 95(9): 1888-95. doi: 10.1016/j.mayocp.2020.06.028. Epub 2020 Jul 19.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.